Rani Therapeutics in News Rani Therapeutics has completed the initial
human safety study of its pill designed to provide injectable
therapies from inside the digestive tract. Rani Therapeutics has
raised $142 million to bring it with its thought poised to potentially
reshape markets dominated by blockbuster injectable biologics across a
variety of signs, which can […]
The post Rani Therapeutics News: Human safety study of its robo
biologic pill completed appeared first on BioTecNika .
https://www.biotecnika.org/2019/03/rani-therapeutics-human-safety-study/
Biotech News
No comments:
Post a Comment